Literature DB >> 8496708

Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score.

C J Mumford1, A Compston.   

Abstract

Current rating scales for multiple sclerosis are unsatisfactory because they score each patient's condition without indicating the clinical context in which that score has been obtained. The Cambridge Multiple Sclerosis Basic Score (CAMBS) offers a solution to this problem by recording current status in the context of the clinical course. CAMBS distinguishes disability from handicap and indicates the independent contribution of relapse and progression to current clinical activity. Single scores of between 1 and 5 are assigned to each of these indices, giving a simple four component analysis for each clinical encounter, e.g. disability 3; relapse 1; progression 2; handicap 1.

Entities:  

Mesh:

Year:  1993        PMID: 8496708     DOI: 10.1007/BF00818706

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

2.  Lethality, duration, and mortality of disseminated sclerosis in Denmark.

Authors:  K Hyllested
Journal:  Acta Psychiatr Scand       Date:  1961       Impact factor: 6.392

3.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

4.  Scoring techniques and problems in the evaluation of change in patients.

Authors:  R J Slater
Journal:  Arch Neurol       Date:  1983-10-21

5.  [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].

Authors:  U Patzold; P Haller; J Haas; P Pocklington; H Deicher
Journal:  Nervenarzt       Date:  1978-05       Impact factor: 1.214

6.  Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps.

Authors:  P H Wood
Journal:  WHO Chron       Date:  1980-10

7.  New concept of critical steps in course of chronic debilitating neurologic disease in evaluation of therapeutic response; a longitudinal study of multiple sclerosis by quantitative evaluation of neurologic involvement and disability.

Authors:  L ALEXANDER
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-09

8.  Use of the Nottingham Health Profile with patients after a stroke.

Authors:  S Ebrahim; D Barer; F Nouri
Journal:  J Epidemiol Community Health       Date:  1986-06       Impact factor: 3.710

9.  Multiple sclerosis in the Cambridge health district of east Anglia.

Authors:  C J Mumford; M B Fraser; N W Wood; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

10.  Substantive and methodological issues in a rating of cognitive and psychological function in multiple sclerosis.

Authors:  R Kaplan
Journal:  Acta Neurol Scand Suppl       Date:  1984
View more
  9 in total

1.  Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.

Authors:  A M Novakovic; E H J Krekels; A Munafo; S Ueckert; M O Karlsson
Journal:  AAPS J       Date:  2016-09-15       Impact factor: 4.009

2.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

Authors:  C Heesen; L Nawrath; C Reich; N Bauer; K-H Schulz; S M Gold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

3.  European Society for Stereotactic and Functional Neurosurgery. Milan, Italy, June 12-15, 1996. Abstracts.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  A comparison of two neurologic scoring instruments for multiple sclerosis.

Authors:  J A Koziol; A Frutos; J C Sipe; J S Romine; E Beutler
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

5.  Multiple sclerosis in sibling pairs: an analysis of 250 families.

Authors:  J Chataway; A Mander; N Robertson; S Sawcer; J Deans; M Fraser; S Broadley; D Clayton; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 6.  What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.

Authors:  Bilge Piri Çinar; Yüksel Güven Yorgun
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

7.  Why not? - Communicating stochastic information by use of unsorted frequency pictograms - a randomised controlled trial.

Authors:  Jürgen Kasper; Christoph Heesen; Sascha Köpke; Ingrid Mühlhauser; Matthias Lenz
Journal:  Psychosoc Med       Date:  2011-11-02

8.  A new graphical format to communicate treatment effects to patients-A web-based randomized controlled trial.

Authors:  Jürgen Kasper; Adrian van de Roemer; Jana Pöttgen; Anne Rahn; Imke Backhus; Yasemin Bay; Sascha Köpke; Christoph Heesen
Journal:  Health Expect       Date:  2016-12-16       Impact factor: 3.377

Review 9.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.

Authors:  Sandra Meyer-Moock; You-Shan Feng; Mathias Maeurer; Franz-Werner Dippel; Thomas Kohlmann
Journal:  BMC Neurol       Date:  2014-03-25       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.